[SLN] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -27.01%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 244 0 16 770 0 15 117 13.02%
PBT -22,870 -20,526 -3,775 -10,362 -9,429 -11,980 -9,002 16.80%
Tax -3,288 -2,115 -2,157 -1,922 -2,784 -892 -70 89.89%
NP -19,582 -18,411 -1,618 -8,440 -6,645 -11,088 -9,002 13.82%
Tax Rate - - - - - - - -
Total Cost 19,826 18,411 1,634 9,210 6,645 11,103 9,119 13.81%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -8,025.41 0.00 -10,112.50 -1,096.10 0.00 -73,920.00 -7,694.02 0.70%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.78 -0.79 -0.07 -0.36 -0.31 -0.66 -0.61 4.18%
EPS Diluted -0.78 -0.79 -0.07 -0.36 -0.31 -0.66 -0.61 4.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.